Fierce Pharma

APRIL 3, 2024

Fifteen years after gaining its first FDA approval for Fanapt (iloperidone) to treat schizophrenia, Vanda Pharmaceuticals has scored again with the same antipsychotic drug. | Fifteen years after gaining its first FDA approval for Fanapt (iloperidone) to treat schizophrenia, Vanda Pharmaceuticals has scored again with the same antipsychotic drug. The FDA has signed off on Fanapt tablets to treat adults with manic or mixed episodes associated with bipolar I disorder.

FDA 261

FDA Pharmaceutical 261

PharmaVoice

APRIL 3, 2024

AMR is a growing threat, but with little financial incentive to pick up the torch, government and nonprofit collaborations are keeping the R&D flames burning.

Government 130

Government Pharma 130

Fierce Pharma

APRIL 3, 2024

Demand fluctuations have spurred Thermo Fisher Scientific to downsize at the plasmid DNA manufacturing facility the company opened a little less than three years ago, putting jobs on the chopping b | Demand fluctuations have spurred Thermo Fisher Scientific to downsize at the plasmid DNA manufacturing facility the company opened a little less than three years ago, putting jobs on the chopping block.

Manufacturing 260

Manufacturing 260

MedCity News

APRIL 3, 2024

In a letter, several stakeholders urged the Drug Enforcement Administration to release a revised proposed rule on the virtual prescribing of controlled substances. This comes as Covid-19 flexibilities that allow controlled substances to be prescribed via telehealth without an in-person exam are set to expire at the end of the year. The post 200 Stakeholders Push DEA for Updated Proposed Rule on Virtual Prescribing of Controlled Substances appeared first on MedCity News.

107

107

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

APRIL 3, 2024

Medicare drug price negotiations under the Inflation Reduction Act are steadily progressing after drugmakers recently submitted their counteroffers to the government's initial pricing proposals.

Government 218

Government Pharma 218

Copyright Clearance Center

APRIL 3, 2024

In today’s Kitchen Essentials interview, Roger Schonfeld speaks with Tracey Armstrong of CCC, the information solutions provider to organizations around the world.

98

98

PharmaTimes

APRIL 3, 2024

The third most common and serious form of cancer affects over 43,000 people every year in the UK

Patients 107

Patients 107

MedCity News

APRIL 3, 2024

In a new era of cost-conscientiousness in MA, supplemental benefits will be assessed on their usefulness — to both payers and beneficiaries The post Supplemental Benefits Must Return to Value appeared first on MedCity News.

99

99

Clarivate

APRIL 3, 2024

The business world is experiencing rapid, profound and unprecedented change—from the “great retirement” of the baby boom generation to the impact of artificial intelligence (AI). How will corporate and law firm intellectual property (IP) professionals navigate this shifting landscape successfully? We explored these timely topics with a panel of experts, capturing their insights in a new white paper entitled “The future of the IP legal profession: Balancing the rise of artificial intelligence wit

Management 59

Management Specialization Training Government 59

MedCity News

APRIL 3, 2024

Antibody specialist Genmab makes most of its money from drugs developed and commercialized by partners. Acquiring ProfoundBio brings antibody drug conjugates that Genmab can develop on its own as it continues diversifying its business beyond strategic alliances. The post Genmab Adds More ADC Firepower With $1.8B ProfoundBio Acquisition appeared first on MedCity News.

Biopharma 93

Biopharma Pharma 93

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Eversana Intouch

APRIL 3, 2024

When we hear the topic “Modular Content and MLR Relationship,” we think and hear of the challenges with medical, legal and regulatory (MLR). Marketers are under immense pressure because omnichannel puts more demands on marketing to produce more content. But what’s really exciting is that AI is going to create the efficiencies that finally enable us to pull through that content.

Marketing 59

Marketing Pharma Medical Healthcare 59

PharmaTimes

APRIL 3, 2024

The progressive neurodegenerative disease is estimated to affect 24 million people globally

86

86

Pharmaceutical Commerce

APRIL 3, 2024

An exploration of the new demands in cold-chain visibility and sustainability—and the resulting tech-driven efforts to address them—leads off our coverage in this month's issue.

Leads 52

Leads 52

European Pharmaceutical Review

APRIL 3, 2024

Research by Roots Analysis predicts the pharmaceutical contract manufacturing market will value $140 billion by 2030. As such, the sector is expected to grow at a compounded annual growth rate (CAGR) of 6.5 percent between 2022-2030. The report noted that there has been “considerable” merger and acquisition activity in recent years within the pharmaceutical contract manufacturing market.

Manufacturing 52

Manufacturing Pharmaceutical Marketing 52

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

Rep-Lite

APRIL 3, 2024

The medical sales industry plays a crucial role in connecting healthcare providers with innovative medical products and technologies. While the goal is ultimately to improve patient outcomes, the competitive nature of the industry can sometimes lead to ethical dilemmas. Ethical considerations in medical sales require constant vigilance and a commitment to putting patient well-being at the forefront of every interaction.

Ethics 52

Ethics Medical sales Competition Sales 52

ALULA

APRIL 3, 2024

Tired of managing a team that goes through the motions? You’re not alone. This year’s global trends confirm that leaders understand the value of human performance for enterprise strength as well as business success. How can you unlock the true potential of your team to create a powerhouse of innovation and engagement?

Management 52

Management 52

Pharmaceutical Commerce

APRIL 3, 2024

Although time has welcomed novel advances in the space, new challenges pertaining to data and the physical technology, along with visibility and sustainability, are emerging.

Pharma 52

Pharma 52

PharmExec

APRIL 3, 2024

Approval comes amid positive results from TRILUMINATE trial, which demonstrated improvement in 90% of participants treated for a leaky tricuspid heart valve.

Medical 52

Medical FDA 52

Advertisement

Pharmaceutical Commerce

APRIL 3, 2024

We'll be back in Lyon, France, this month to capture the latest insights and advances in pharma logistics—as leaders seek to build the supply chains of the future.

Pharma 52

Pharma 52

PharmExec

APRIL 3, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Pharmaceutical Commerce

APRIL 3, 2024

Cohort study examines the potential for spending to significantly decrease for individuals who use these generic versions of biologics.

Competition 52

Competition Patients 52

PharmExec

APRIL 3, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Commerce

APRIL 3, 2024

Pharma Commerce makes a return trip to Philly for insights on the latest approaches in patient assistance and adherence.

Patients 52

Patients Pharma 52

PharmExec

APRIL 3, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52

Pharma 52

Pharmaceutical Commerce

APRIL 3, 2024

Click the title above for a link to open the Pharmaceutical Commerce April 2024 issue in an interactive PDF format.

Pharmaceutical 52

Pharmaceutical 52

PharmExec

APRIL 3, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Advertisement

Distribution

PharmaTech

APRIL 3, 2024

Our Future Health, a health research program in the UK, has welcomed Novartis as a new industry partner.

52

52

PharmExec

APRIL 3, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Pharmaceutical Commerce

APRIL 3, 2024

The two company’s will provide consumers with a platform where they can compare drug prices.

52

52

PharmExec

APRIL 3, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharmaceutical 52

Pharmaceutical FDA 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales